Stockreport

DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy [Yahoo! Finance]

AstraZeneca PLC Ordinary Shares  (AZN) 
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF If approved, DATROWAY could become the standard of care in this setting TOKYO & BASKING RIDGE, N.J., February 03, 2026 BUSINESS WIRE )--Daiichi Sankyo (TSE: 4568) and [Read more]